Zhang Han, Wu Ye, Jiang Yuwu
Department of Pediatrics, Peking University First Hospital, Beijing, China.
Front Pediatr. 2021 Sep 16;9:699568. doi: 10.3389/fped.2021.699568. eCollection 2021.
(Cystathionine-β-synthase-pair Domain Divalent Metal Cation Transport Mediator 2) pathogenic variants have been reported to cause hypomagnesemia, epilepsy, and intellectual disability/developmental delay (ID/DD). We identified two new cases with novel pathogenic variants, c.814T>C and c.976G>C. They both presented with infantile-onset epilepsy with DD and hypomagnesemia refractory to magnesium supplementation. To date, 21 cases with -related disorders have been reported. We combined all 23 cases to analyze the features of -related disorders. The phenotypes can be classified into three types: type 1, autosomal dominant (AD) inherited simple hypomagnesemia; type 2, AD inherited hypomagnesemia with epilepsy and ID/DD; and type 3, autosomal recessive (AR) inherited hypomagnesemia with epilepsy and ID/DD. All five type 1 cases had no epilepsy or ID/DD; they all had hypomagnesemia, and three of them presented with symptoms secondary to hypomagnesemia. Fifteen type 2 patients could have ID/DD and seizures, which can be controlled with antiseizure medications (ASMs); their variations clustered in the DUF21 domain of CNNM2. All three type 3 patients had seizures from 1 to 6 days after birth; the seizures were refractory, and 1/3 had status epilepticus; ID/DD in these AR-inherited cases was more severe than that of AD-inherited cases; they all had abnormalities of brain magnetic resonance imaging (MRI). Except for one patient whose serum magnesium was the lower limit of normal, others had definite hypomagnesemia. Hypomagnesemia could be improved after magnesium supplement but could not return to the normal level. Variations in the CBS2 domain may be related to lower serum magnesium. However, there was no significant difference in the level of serum magnesium among the patients with three different types of -related disorders. The severity of different phenotypes was therefore not explained by decreased serum magnesium. We expanded the spectrum of variants and classified the phenotypes of -related disorders into three types. We found that DUF21 domain variations were most associated with -related central nervous system phenotypes, whereas hypomagnesemia was more pronounced in patients with CBS2 domain variations, and AR-inherited -related disorders had the most severe phenotype. These results provide important clues for further functional studies of and provide basic foundations for more accurate genetic counseling.
据报道,(胱硫醚-β-合酶配对结构域二价金属阳离子转运介质2)致病变异可导致低镁血症、癫痫和智力残疾/发育迟缓(ID/DD)。我们鉴定出两例携带新型致病变异c.814T>C和c.976G>C的新病例。他们均表现为婴儿期起病的癫痫伴发育迟缓及对补充镁剂难治的低镁血症。迄今为止,已报道了21例相关疾病病例。我们将所有23例病例合并起来分析相关疾病的特征。其表型可分为三种类型:1型,常染色体显性(AD)遗传的单纯低镁血症;2型,AD遗传的低镁血症伴癫痫和ID/DD;3型,常染色体隐性(AR)遗传的低镁血症伴癫痫和ID/DD。所有5例1型病例均无癫痫或ID/DD;他们均有低镁血症,其中3例出现低镁血症继发症状。15例2型患者可出现ID/DD和癫痫发作,癫痫发作可用抗癫痫药物(ASM)控制;他们的变异集中在CNNM2的DUF21结构域。所有3例3型患者在出生后1至6天出现癫痫发作;癫痫发作难治,1/3患者出现癫痫持续状态;这些AR遗传病例中的ID/DD比AD遗传病例更严重;他们均有脑磁共振成像(MRI)异常。除1例患者血清镁为正常下限外,其他患者均有明确低镁血症。补充镁剂后低镁血症可改善,但不能恢复至正常水平。CBS2结构域变异可能与血清镁降低有关。然而,三种不同类型相关疾病患者的血清镁水平无显著差异。因此,不同表型的严重程度不能用血清镁降低来解释。我们扩展了相关变异谱,并将相关疾病的表型分为三种类型。我们发现DUF21结构域变异与相关中枢神经系统表型最相关,而CBS2结构域变异患者的低镁血症更明显,AR遗传的相关疾病表型最严重。这些结果为进一步开展相关功能研究提供了重要线索,并为更准确的遗传咨询提供了基础依据。